Skip to content

Clinical study on Lip Balm participants with lip dryness

Clinical Evaluation of efficacy and safety of Lip Balm in mild to moderate lip dryness - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094141
Enrollment
30
Registered
2025-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Emami Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects suffering from mild to moderate dryness of lips

Exclusion criteria

Exclusion criteria: 1. History of lip injections or lip surgery, chronically dry or chapped lip 2. History of recent or ongoing use of medication that can have dryness as a side effect. 3. Subject with severe dermatological disorders that might interfere with the study evaluation 4. Known cases of any Hypersensitivity to Lip balm ingredients 5. Subjects who have participated in any other clinical study since last 3 months 6. Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study

Design outcomes

Primary

MeasureTime frame
Change in dryness of lipsTimepoint: Baseline visit (day 0), day 15 and end of study visit (Day 30)

Secondary

MeasureTime frame
1. Change in lips fine lines, hydration, colour 2. Global assessment of overall change in lip dryness 3. Assessment of skin patch test using Dermal Response Score. 4. Assessment of safety by observing episodes, severity and duration of any allergic reactions and adverse events Timepoint: Baseline visit (day 0), day 15 and end of study visit (Day 30)

Countries

India

Contacts

Public ContactDr Sanjay Tamoli

Target Institute of Medical Education and Research Pvt. Ltd

targetinstitute@yahoo.com9322522252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026